Common Equity: The sum of all common equity items.
Seres Therapeutics, Inc. (MCRB) had Common Equity of $43.70M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.35M |
|
$8.20M |
|
-- |
|
$0.35M |
|
$22.83M |
|
$-22.48M |
|
$30.68M |
|
$8.20M |
|
$8.20M |
|
$8.20M |
|
$8.20M |
|
$8.20M |
|
$8.20M |
|
$-22.48M |
|
$-21.43M |
|
8.76M |
|
8.77M |
|
$0.94 |
|
$0.94 |
|
| Balance Sheet Financials | |
$51.53M |
|
$8.58M |
|
$91.95M |
|
$143.47M |
|
$22.43M |
|
-- |
|
$77.35M |
|
$99.78M |
|
|
Common Equity |
$43.70M |
$43.70M |
|
$43.70M |
|
8.77M |
|
| Cash Flow Statement Financials | |
$15.83M |
|
$-0.22M |
|
$1.24M |
|
$39.46M |
|
$56.31M |
|
$16.84M |
|
$7.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-6403.70% |
|
-6403.70% |
|
-- |
|
2337.32% |
|
2337.32% |
|
$15.60M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.45 |
|
199.23 |
|
18.77% |
|
18.77% |
|
5.72% |
|
18.77% |
|
$4.99 |
|
$1.78 |
|
$1.80 |
|